Blood Test May Identify New Biomarkers for Parkinson's
Researchers at The Mount Sinai Hospital in New York have developed a new blood test that they say can better identify biomarkers for Parkinson's disease, which could lead to earlier detection of the condition. Stuart Sealfon, MD, chairman of the Department of Neurology at Mount Sinai, and colleagues analyzed blood of four groups of mice with genetic material, such as RNA, that they thought could be Parkinson's biomarkers. "If you can improve your ability to diagnose the disease more specifically and identify new subtypes, this can help overcome the hurdle in developing new treatments for Parkinson's and other brain diseases," Sealfon said in a statement.
- Dr. Stuart Sealfon, Glickenhaus Professor and Chairman of the Department of Neurology, Professor, Pharmacology and Systems Therapeutics, Neuroscience, Icahn School of Medicine at Mount Sinai, Chair, Department of Neurology, Mount Sinai Health System